Skip to main content

Table 2 Pathways that are enriched among target genes of miRNA-152-3p

From: The expression of miRNA-152-3p and miRNA-185 in tumor tissues versus margin tissues of patients with chemo-treated breast cancer

Gene set Pathway name FDR P-value Fold enrichment detail
hsa05215 Prostate cancer 5.9238E−6 2.8840E−9 O = 11; E = 0.96; R = 11.37
R-HSA-8943723 Regulation of PTEN mRNA translation 8.1607E−6 1.1011E−8 O = 5; E = 0.08; R = 55.72
hsa04151 PI3K-Akt signaling pathway 8.1607E−6 1.1919E−8 O = 18; E = 3.52; R = 5.10
hsa05206 MicroRNAs in cancer 1.5061E−5 2.9330E−8 O = 12; E = 1.49; R = 8.02
hsa04550 Signaling pathways regulating pluripotency of stem cells 5.2459E−5 1.2770E−7 O = 11; E = 1.38; R = 7.93
hsa05224 Breast cancer 6.8102E−5 2.2617E−7 O = 11; E = 1.46; R = 7.50
hsa05165 Human papillomavirus infection 6.8102E−5 2.3209E−7 O = 16; E = 3.37; R = 4.73
R-HSA-426496 Post-transcriptional silencing by small RNAs 8.2303E−5 3.2056E−7 O = 4; E = 0.06; R = 57.32
hsa05214 Glioma 1.0421E−4 4.8141E−7 O = 8; E = 0.70; R = 11.30
R-HSA-8934593 Regulation of RUNX1 Expression and Activity 1.0421E−4 5.0736E−7 O = 5; E = 0.16; R = 29.50
  1. E number of expected gene in the category, FDR false discovery rate, O number of observed target genes in the category, R fold enrichment